aluates Reports

$ 0.0

Automative

Global Chemotherapy for Neuroblastoma Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-12F14822

Global Chemotherapy for Neuroblastoma Market Research Report 2023

BUY CHAPTERS

Global Chemotherapy for Neuroblastoma Market Research Report 2025

Code: QYRE-Auto-12F14822

Report

May 2025

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Baxter Healthcare

Ingenus Pharmaceuticals

ANI Pharmaceuticals

Teva Pharmaceuticals

Qilu Pharmaceutical

Pfizer Inc

Hikma Pharmaceuticals

Fresenius Kabi

Accord Healthcare

Viatris

Chemotherapy for Neuroblastoma Market Size

The global market for Chemotherapy for Neuroblastoma was valued at US$ 133 million in the year 2024 and is projected to reach a revised size of US$ 182 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Chemotherapy for Neuroblastoma Market

Chemotherapy (chemo) is the use of anti-cancer drugs, which are usually given into a vein. The drugs enter the bloodstream and travel throughout the body to reach and destroy cancer cells. This makes chemo useful for treating neuroblastoma, especially if it can"t all be removed with surgery. The most common combination of drugs includes cisplatin (or carboplatin), cyclophosphamide, doxorubicin, vincristine, and etoposide, but others may be used.

North American market for Chemotherapy for Neuroblastoma is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Chemotherapy for Neuroblastoma is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Chemotherapy for Neuroblastoma in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Chemotherapy for Neuroblastoma include Baxter Healthcare, Ingenus Pharmaceuticals, ANI Pharmaceuticals, Teva Pharmaceuticals, Qilu Pharmaceutical, Pfizer, Hikma Pharmaceuticals, Fresenius Kabi, Accord Healthcare, Viatris, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Chemotherapy for Neuroblastoma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemotherapy for Neuroblastoma.

The Chemotherapy for Neuroblastoma market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chemotherapy for Neuroblastoma market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chemotherapy for Neuroblastoma companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Chemotherapy for Neuroblastoma Market Report

Report Metric	Details
Report Name	Chemotherapy for Neuroblastoma Market
Accounted market size in year	US$ 133 million
Forecasted market size in 2031	US$ 182 million
CAGR	4.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Cyclophosphamide Cisplatin or Carboplatin Vincristine Doxorubicin (Adriamycin) Etoposide Other
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Baxter Healthcare, Ingenus Pharmaceuticals, ANI Pharmaceuticals, Teva Pharmaceuticals, Qilu Pharmaceutical, Pfizer, Hikma Pharmaceuticals, Fresenius Kabi, Accord Healthcare, Viatris
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chemotherapy for Neuroblastoma company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Chemotherapy for Neuroblastoma Market growing?

Ans: The Chemotherapy for Neuroblastoma Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Chemotherapy for Neuroblastoma Market size in 2031?

Ans: The Chemotherapy for Neuroblastoma Market size in 2031 will be US$ 182 million.

Who are the main players in the Chemotherapy for Neuroblastoma Market report?

Ans: The main players in the Chemotherapy for Neuroblastoma Market are Baxter Healthcare, Ingenus Pharmaceuticals, ANI Pharmaceuticals, Teva Pharmaceuticals, Qilu Pharmaceutical, Pfizer, Hikma Pharmaceuticals, Fresenius Kabi, Accord Healthcare, Viatris

What are the Application segmentation covered in the Chemotherapy for Neuroblastoma Market report?

Ans: The Applications covered in the Chemotherapy for Neuroblastoma Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Chemotherapy for Neuroblastoma Market report?

Ans: The Types covered in the Chemotherapy for Neuroblastoma Market report are Cyclophosphamide, Cisplatin or Carboplatin, Vincristine, Doxorubicin (Adriamycin), Etoposide, Other

Recommended Reports

Cancer Drug Markets

Cancer Treatment Types

Neuro Cancer & Related

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Chemotherapy for Neuroblastoma Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Cyclophosphamide

1.2.3 Cisplatin or Carboplatin

1.2.4 Vincristine

1.2.5 Doxorubicin (Adriamycin)

1.2.6 Etoposide

1.2.7 Other

1.3 Market by Application

1.3.1 Global Chemotherapy for Neuroblastoma Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Chemotherapy for Neuroblastoma Market Perspective (2020-2031)

2.2 Global Chemotherapy for Neuroblastoma Growth Trends by Region

2.2.1 Global Chemotherapy for Neuroblastoma Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Chemotherapy for Neuroblastoma Historic Market Size by Region (2020-2025)

2.2.3 Chemotherapy for Neuroblastoma Forecasted Market Size by Region (2026-2031)

2.3 Chemotherapy for Neuroblastoma Market Dynamics

2.3.1 Chemotherapy for Neuroblastoma Industry Trends

2.3.2 Chemotherapy for Neuroblastoma Market Drivers

2.3.3 Chemotherapy for Neuroblastoma Market Challenges

2.3.4 Chemotherapy for Neuroblastoma Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Chemotherapy for Neuroblastoma Players by Revenue

3.1.1 Global Top Chemotherapy for Neuroblastoma Players by Revenue (2020-2025)

3.1.2 Global Chemotherapy for Neuroblastoma Revenue Market Share by Players (2020-2025)

3.2 Global Chemotherapy for Neuroblastoma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Chemotherapy for Neuroblastoma Revenue

3.4 Global Chemotherapy for Neuroblastoma Market Concentration Ratio

3.4.1 Global Chemotherapy for Neuroblastoma Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Chemotherapy for Neuroblastoma Revenue in 2024

3.5 Global Key Players of Chemotherapy for Neuroblastoma Head office and Area Served

3.6 Global Key Players of Chemotherapy for Neuroblastoma, Product and Application

3.7 Global Key Players of Chemotherapy for Neuroblastoma, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Chemotherapy for Neuroblastoma Breakdown Data by Type

4.1 Global Chemotherapy for Neuroblastoma Historic Market Size by Type (2020-2025)

4.2 Global Chemotherapy for Neuroblastoma Forecasted Market Size by Type (2026-2031)

5 Chemotherapy for Neuroblastoma Breakdown Data by Application

5.1 Global Chemotherapy for Neuroblastoma Historic Market Size by Application (2020-2025)

5.2 Global Chemotherapy for Neuroblastoma Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Chemotherapy for Neuroblastoma Market Size (2020-2031)

6.2 North America Chemotherapy for Neuroblastoma Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Chemotherapy for Neuroblastoma Market Size by Country (2020-2025)

6.4 North America Chemotherapy for Neuroblastoma Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Chemotherapy for Neuroblastoma Market Size (2020-2031)

7.2 Europe Chemotherapy for Neuroblastoma Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Chemotherapy for Neuroblastoma Market Size by Country (2020-2025)

7.4 Europe Chemotherapy for Neuroblastoma Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Chemotherapy for Neuroblastoma Market Size (2020-2031)

8.2 Asia-Pacific Chemotherapy for Neuroblastoma Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Chemotherapy for Neuroblastoma Market Size by Region (2020-2025)

8.4 Asia-Pacific Chemotherapy for Neuroblastoma Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Chemotherapy for Neuroblastoma Market Size (2020-2031)

9.2 Latin America Chemotherapy for Neuroblastoma Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Chemotherapy for Neuroblastoma Market Size by Country (2020-2025)

9.4 Latin America Chemotherapy for Neuroblastoma Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Chemotherapy for Neuroblastoma Market Size (2020-2031)

10.2 Middle East & Africa Chemotherapy for Neuroblastoma Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Chemotherapy for Neuroblastoma Market Size by Country (2020-2025)

10.4 Middle East & Africa Chemotherapy for Neuroblastoma Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Baxter Healthcare

11.1.1 Baxter Healthcare Company Details

11.1.2 Baxter Healthcare Business Overview

11.1.3 Baxter Healthcare Chemotherapy for Neuroblastoma Introduction

11.1.4 Baxter Healthcare Revenue in Chemotherapy for Neuroblastoma Business (2020-2025)

11.1.5 Baxter Healthcare Recent Development

11.2 Ingenus Pharmaceuticals

11.2.1 Ingenus Pharmaceuticals Company Details

11.2.2 Ingenus Pharmaceuticals Business Overview

11.2.3 Ingenus Pharmaceuticals Chemotherapy for Neuroblastoma Introduction

11.2.4 Ingenus Pharmaceuticals Revenue in Chemotherapy for Neuroblastoma Business (2020-2025)

11.2.5 Ingenus Pharmaceuticals Recent Development

11.3 ANI Pharmaceuticals

11.3.1 ANI Pharmaceuticals Company Details

11.3.2 ANI Pharmaceuticals Business Overview

11.3.3 ANI Pharmaceuticals Chemotherapy for Neuroblastoma Introduction

11.3.4 ANI Pharmaceuticals Revenue in Chemotherapy for Neuroblastoma Business (2020-2025)

11.3.5 ANI Pharmaceuticals Recent Development

11.4 Teva Pharmaceuticals

11.4.1 Teva Pharmaceuticals Company Details

11.4.2 Teva Pharmaceuticals Business Overview

11.4.3 Teva Pharmaceuticals Chemotherapy for Neuroblastoma Introduction

11.4.4 Teva Pharmaceuticals Revenue in Chemotherapy for Neuroblastoma Business (2020-2025)

11.4.5 Teva Pharmaceuticals Recent Development

11.5 Qilu Pharmaceutical

11.5.1 Qilu Pharmaceutical Company Details

11.5.2 Qilu Pharmaceutical Business Overview

11.5.3 Qilu Pharmaceutical Chemotherapy for Neuroblastoma Introduction

11.5.4 Qilu Pharmaceutical Revenue in Chemotherapy for Neuroblastoma Business (2020-2025)

11.5.5 Qilu Pharmaceutical Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Details

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Chemotherapy for Neuroblastoma Introduction

11.6.4 Pfizer Revenue in Chemotherapy for Neuroblastoma Business (2020-2025)

11.6.5 Pfizer Recent Development

11.7 Hikma Pharmaceuticals

11.7.1 Hikma Pharmaceuticals Company Details

11.7.2 Hikma Pharmaceuticals Business Overview

11.7.3 Hikma Pharmaceuticals Chemotherapy for Neuroblastoma Introduction

11.7.4 Hikma Pharmaceuticals Revenue in Chemotherapy for Neuroblastoma Business (2020-2025)

11.7.5 Hikma Pharmaceuticals Recent Development

11.8 Fresenius Kabi

11.8.1 Fresenius Kabi Company Details

11.8.2 Fresenius Kabi Business Overview

11.8.3 Fresenius Kabi Chemotherapy for Neuroblastoma Introduction

11.8.4 Fresenius Kabi Revenue in Chemotherapy for Neuroblastoma Business (2020-2025)

11.8.5 Fresenius Kabi Recent Development

11.9 Accord Healthcare

11.9.1 Accord Healthcare Company Details

11.9.2 Accord Healthcare Business Overview

11.9.3 Accord Healthcare Chemotherapy for Neuroblastoma Introduction

11.9.4 Accord Healthcare Revenue in Chemotherapy for Neuroblastoma Business (2020-2025)

11.9.5 Accord Healthcare Recent Development

11.10 Viatris

11.10.1 Viatris Company Details

11.10.2 Viatris Business Overview

11.10.3 Viatris Chemotherapy for Neuroblastoma Introduction

11.10.4 Viatris Revenue in Chemotherapy for Neuroblastoma Business (2020-2025)

11.10.5 Viatris Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Baxter Healthcare

Ingenus Pharmaceuticals

ANI Pharmaceuticals

Teva Pharmaceuticals

Qilu Pharmaceutical

Pfizer Inc

Hikma Pharmaceuticals

Fresenius Kabi

Accord Healthcare

Viatris

List of Tables

Table 1. Global Chemotherapy for Neuroblastoma Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Cyclophosphamide

Table 3. Key Players of Cisplatin or Carboplatin

Table 4. Key Players of Vincristine

Table 5. Key Players of Doxorubicin (Adriamycin)

Table 6. Key Players of Etoposide

Table 7. Key Players of Other

Table 8. Global Chemotherapy for Neuroblastoma Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Chemotherapy for Neuroblastoma Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Chemotherapy for Neuroblastoma Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global Chemotherapy for Neuroblastoma Market Share by Region (2020-2025)

Table 12. Global Chemotherapy for Neuroblastoma Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global Chemotherapy for Neuroblastoma Market Share by Region (2026-2031)

Table 14. Chemotherapy for Neuroblastoma Market Trends

Table 15. Chemotherapy for Neuroblastoma Market Drivers

Table 16. Chemotherapy for Neuroblastoma Market Challenges

Table 17. Chemotherapy for Neuroblastoma Market Restraints

Table 18. Global Chemotherapy for Neuroblastoma Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Chemotherapy for Neuroblastoma Market Share by Players (2020-2025)

Table 20. Global Top Chemotherapy for Neuroblastoma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy for Neuroblastoma as of 2024)

Table 21. Ranking of Global Top Chemotherapy for Neuroblastoma Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Chemotherapy for Neuroblastoma Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Chemotherapy for Neuroblastoma, Headquarters and Area Served

Table 24. Global Key Players of Chemotherapy for Neuroblastoma, Product and Application

Table 25. Global Key Players of Chemotherapy for Neuroblastoma, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Chemotherapy for Neuroblastoma Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global Chemotherapy for Neuroblastoma Revenue Market Share by Type (2020-2025)

Table 29. Global Chemotherapy for Neuroblastoma Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global Chemotherapy for Neuroblastoma Revenue Market Share by Type (2026-2031)

Table 31. Global Chemotherapy for Neuroblastoma Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global Chemotherapy for Neuroblastoma Revenue Market Share by Application (2020-2025)

Table 33. Global Chemotherapy for Neuroblastoma Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global Chemotherapy for Neuroblastoma Revenue Market Share by Application (2026-2031)

Table 35. North America Chemotherapy for Neuroblastoma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America Chemotherapy for Neuroblastoma Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America Chemotherapy for Neuroblastoma Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe Chemotherapy for Neuroblastoma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe Chemotherapy for Neuroblastoma Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe Chemotherapy for Neuroblastoma Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific Chemotherapy for Neuroblastoma Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific Chemotherapy for Neuroblastoma Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific Chemotherapy for Neuroblastoma Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America Chemotherapy for Neuroblastoma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America Chemotherapy for Neuroblastoma Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America Chemotherapy for Neuroblastoma Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa Chemotherapy for Neuroblastoma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa Chemotherapy for Neuroblastoma Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa Chemotherapy for Neuroblastoma Market Size by Country (2026-2031) & (US$ Million)

Table 50. Baxter Healthcare Company Details

Table 51. Baxter Healthcare Business Overview

Table 52. Baxter Healthcare Chemotherapy for Neuroblastoma Product

Table 53. Baxter Healthcare Revenue in Chemotherapy for Neuroblastoma Business (2020-2025) & (US$ Million)

Table 54. Baxter Healthcare Recent Development

Table 55. Ingenus Pharmaceuticals Company Details

Table 56. Ingenus Pharmaceuticals Business Overview

Table 57. Ingenus Pharmaceuticals Chemotherapy for Neuroblastoma Product

Table 58. Ingenus Pharmaceuticals Revenue in Chemotherapy for Neuroblastoma Business (2020-2025) & (US$ Million)

Table 59. Ingenus Pharmaceuticals Recent Development

Table 60. ANI Pharmaceuticals Company Details

Table 61. ANI Pharmaceuticals Business Overview

Table 62. ANI Pharmaceuticals Chemotherapy for Neuroblastoma Product

Table 63. ANI Pharmaceuticals Revenue in Chemotherapy for Neuroblastoma Business (2020-2025) & (US$ Million)

Table 64. ANI Pharmaceuticals Recent Development

Table 65. Teva Pharmaceuticals Company Details

Table 66. Teva Pharmaceuticals Business Overview

Table 67. Teva Pharmaceuticals Chemotherapy for Neuroblastoma Product

Table 68. Teva Pharmaceuticals Revenue in Chemotherapy for Neuroblastoma Business (2020-2025) & (US$ Million)

Table 69. Teva Pharmaceuticals Recent Development

Table 70. Qilu Pharmaceutical Company Details

Table 71. Qilu Pharmaceutical Business Overview

Table 72. Qilu Pharmaceutical Chemotherapy for Neuroblastoma Product

Table 73. Qilu Pharmaceutical Revenue in Chemotherapy for Neuroblastoma Business (2020-2025) & (US$ Million)

Table 74. Qilu Pharmaceutical Recent Development

Table 75. Pfizer Company Details

Table 76. Pfizer Business Overview

Table 77. Pfizer Chemotherapy for Neuroblastoma Product

Table 78. Pfizer Revenue in Chemotherapy for Neuroblastoma Business (2020-2025) & (US$ Million)

Table 79. Pfizer Recent Development

Table 80. Hikma Pharmaceuticals Company Details

Table 81. Hikma Pharmaceuticals Business Overview

Table 82. Hikma Pharmaceuticals Chemotherapy for Neuroblastoma Product

Table 83. Hikma Pharmaceuticals Revenue in Chemotherapy for Neuroblastoma Business (2020-2025) & (US$ Million)

Table 84. Hikma Pharmaceuticals Recent Development

Table 85. Fresenius Kabi Company Details

Table 86. Fresenius Kabi Business Overview

Table 87. Fresenius Kabi Chemotherapy for Neuroblastoma Product

Table 88. Fresenius Kabi Revenue in Chemotherapy for Neuroblastoma Business (2020-2025) & (US$ Million)

Table 89. Fresenius Kabi Recent Development

Table 90. Accord Healthcare Company Details

Table 91. Accord Healthcare Business Overview

Table 92. Accord Healthcare Chemotherapy for Neuroblastoma Product

Table 93. Accord Healthcare Revenue in Chemotherapy for Neuroblastoma Business (2020-2025) & (US$ Million)

Table 94. Accord Healthcare Recent Development

Table 95. Viatris Company Details

Table 96. Viatris Business Overview

Table 97. Viatris Chemotherapy for Neuroblastoma Product

Table 98. Viatris Revenue in Chemotherapy for Neuroblastoma Business (2020-2025) & (US$ Million)

Table 99. Viatris Recent Development

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

Table 103. Authors List of This Report

List of Figures

Figure 1. Chemotherapy for Neuroblastoma Picture

Figure 2. Global Chemotherapy for Neuroblastoma Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Chemotherapy for Neuroblastoma Market Share by Type: 2024 VS 2031

Figure 4. Cyclophosphamide Features

Figure 5. Cisplatin or Carboplatin Features

Figure 6. Vincristine Features

Figure 7. Doxorubicin (Adriamycin) Features

Figure 8. Etoposide Features

Figure 9. Other Features

Figure 10. Global Chemotherapy for Neuroblastoma Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global Chemotherapy for Neuroblastoma Market Share by Application: 2024 VS 2031

Figure 12. Hospital Case Studies

Figure 13. Clinic Case Studies

Figure 14. Other Case Studies

Figure 15. Chemotherapy for Neuroblastoma Report Years Considered

Figure 16. Global Chemotherapy for Neuroblastoma Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Chemotherapy for Neuroblastoma Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Chemotherapy for Neuroblastoma Market Share by Region: 2024 VS 2031

Figure 19. Global Chemotherapy for Neuroblastoma Market Share by Players in 2024

Figure 20. Global Top Chemotherapy for Neuroblastoma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy for Neuroblastoma as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Chemotherapy for Neuroblastoma Revenue in 2024

Figure 22. North America Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Chemotherapy for Neuroblastoma Market Share by Country (2020-2031)

Figure 24. United States Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Chemotherapy for Neuroblastoma Market Share by Country (2020-2031)

Figure 28. Germany Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Chemotherapy for Neuroblastoma Market Share by Region (2020-2031)

Figure 36. China Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Chemotherapy for Neuroblastoma Market Share by Country (2020-2031)

Figure 44. Mexico Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Chemotherapy for Neuroblastoma Market Share by Country (2020-2031)

Figure 48. Turkey Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Chemotherapy for Neuroblastoma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Baxter Healthcare Revenue Growth Rate in Chemotherapy for Neuroblastoma Business (2020-2025)

Figure 52. Ingenus Pharmaceuticals Revenue Growth Rate in Chemotherapy for Neuroblastoma Business (2020-2025)

Figure 53. ANI Pharmaceuticals Revenue Growth Rate in Chemotherapy for Neuroblastoma Business (2020-2025)

Figure 54. Teva Pharmaceuticals Revenue Growth Rate in Chemotherapy for Neuroblastoma Business (2020-2025)

Figure 55. Qilu Pharmaceutical Revenue Growth Rate in Chemotherapy for Neuroblastoma Business (2020-2025)

Figure 56. Pfizer Revenue Growth Rate in Chemotherapy for Neuroblastoma Business (2020-2025)

Figure 57. Hikma Pharmaceuticals Revenue Growth Rate in Chemotherapy for Neuroblastoma Business (2020-2025)

Figure 58. Fresenius Kabi Revenue Growth Rate in Chemotherapy for Neuroblastoma Business (2020-2025)

Figure 59. Accord Healthcare Revenue Growth Rate in Chemotherapy for Neuroblastoma Business (2020-2025)

Figure 60. Viatris Revenue Growth Rate in Chemotherapy for Neuroblastoma Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Neuroblastoma Chemotherapy Drugs Market Research Report 2025

Global Neuroblastoma Treatment Drugs Market Research Report 2025

Global Neuroblastoma Drugs Market Research Report 2024

Immunotherapy Drugs for Neuroblastoma Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cisplatin Chemotherapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Breast Cancer Treatment Drugs Market Insights Forecast to 2030

Global Neuroblastoma Treatment Market Insights Forecast to 2030

Immunotherapy for Neuroblastoma Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chemotherapy Drug Market Insights Forecast to 2030

Global Glioma Treatment Market Research Report 2025

Nephroblastoma Chemotherapy Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vincristine Market Research Report 2024

Global Platinum based Cancer Drug Market Insights Forecast to 2030

Global Chemotherapy Syringe Pump Market Insights Forecast to 2030

Platinum based Anticancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vinblastine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Chemotherapy Drugs Market Research Report 2024

Global Anticancer Drugs Market Research Report 2025

Cyclophosphamide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions